Inventors:
Ellen Baron - Los Altos CA, US
Wolf-Dieter Engel - Feldafing, DE
Gerd Haberhausen - Penzberg, DE
Peter Kaspar - Penzberg, DE
Andreas Kogelnik - Palo Alto CA, US
International Classification:
C12Q 1/68, C12P 19/34
Abstract:
The present invention is directed to a method for analyzing the presence of a bacterial pathogen in a clinical sample comprising the steps of (i) at least partially isolating nucleic acid from said sample, characterized in that said nucleic acid is selected from a group consisting of either total nucleic acid, total DNA or total RNA, (ii) quantifying the amount of nucleic acid comprising a preselected sequence which is specific for said bacterial pathogen, and (iii) determining whether said amount of nucleic acid comprising a preselected sequence which is specific for said bacterial pathogen exceeds a first predetermined cut off value.